These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20568733)

  • 1. Kinetic evidence for the sequential association of insulin binding sites 1 and 2 to the insulin receptor and the influence of receptor isoform.
    Thorsøe KS; Schlein M; Steensgaard DB; Brandt J; Schluckebier G; Naver H
    Biochemistry; 2010 Jul; 49(29):6234-46. PubMed ID: 20568733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
    Ward CW; Lawrence MC
    Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thermodynamic study of ligand binding to the first three domains of the human insulin receptor: relationship between the receptor alpha-chain C-terminal peptide and the site 1 insulin mimetic peptides.
    Menting JG; Ward CW; Margetts MB; Lawrence MC
    Biochemistry; 2009 Jun; 48(23):5492-500. PubMed ID: 19459609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms.
    Knudsen L; De Meyts P; Kiselyov VV
    Biochem J; 2011 Dec; 440(3):397-403. PubMed ID: 21838706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into ligand-induced activation of the insulin receptor.
    Ward C; Lawrence M; Streltsov V; Garrett T; McKern N; Lou MZ; Lovrecz G; Adams T
    Acta Physiol (Oxf); 2008 Jan; 192(1):3-9. PubMed ID: 18171424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review.
    Denley A; Wallace JC; Cosgrove LJ; Forbes BE
    Horm Metab Res; 2003; 35(11-12):778-85. PubMed ID: 14710358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells.
    Nielsen D; Gyllberg H; Ostlund P; Bergman T; Bedecs K
    Biochem J; 2004 Jun; 380(Pt 2):571-9. PubMed ID: 15025560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-binding domain of insulin receptor is encoded by exon 2 and exon 3.
    Yip CC
    J Cell Biochem; 1992 Jan; 48(1):19-25. PubMed ID: 1316357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of differential intracellular signaling from the insulin receptor.
    Jensen M; De Meyts P
    Vitam Horm; 2009; 80():51-75. PubMed ID: 19251034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding.
    Glendorf T; Sørensen AR; Nishimura E; Pettersson I; Kjeldsen T
    Biochemistry; 2008 Apr; 47(16):4743-51. PubMed ID: 18376848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P; Wiley S; Pawson T
    Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B.
    Giudice J; Leskow FC; Arndt-Jovin DJ; Jovin TM; Jares-Erijman EA
    J Cell Sci; 2011 Mar; 124(Pt 5):801-11. PubMed ID: 21303927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
    Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
    Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct determination of the insulin-insulin receptor interface using transferred cross-saturation experiments.
    Nakamura T; Takahashi H; Takahashi M; Shimba N; Suzuki E; Shimada I
    J Med Chem; 2010 Mar; 53(5):1917-22. PubMed ID: 20158183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
    Kolychev AP
    Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a second ligand binding site of the insulin receptor.
    Hao C; Whittaker L; Whittaker J
    Biochem Biophys Res Commun; 2006 Aug; 347(1):334-9. PubMed ID: 16814253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual insulin binding to cells expressing an insulin receptor mutated at cysteine 524.
    Bilan PJ; Yip CC
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1891-8. PubMed ID: 7811279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
    Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structural switch in a mutant insulin exposes key residues for receptor binding.
    Ludvigsen S; Olsen HB; Kaarsholm NC
    J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
    Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
    Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.